Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abivax SA - American Depositary Shares
(NQ:
ABVX
)
113.55
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
28,087
Open
113.55
Bid (Size)
111.51 (100)
Ask (Size)
111.83 (100)
Prev. Close
113.55
Today's Range
113.55 - 113.55
52wk Range
5.590 - 148.83
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Hedge Fund Wagers $36 Million on Biotech Denali After First FDA Approval
↗
May 18, 2026
This biotech develops therapies for neurodegenerative diseases, advancing a broad pipeline through strategic pharmaceutical partnerships.
Via
The Motley Fool
Topics
Regulatory Compliance
Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?
↗
May 18, 2026
Beam Therapeutics develops precision genetic medicines using base editing technology to target serious inherited diseases.
Via
The Motley Fool
Performance
YTD
-15.1%
-15.1%
1 Month
-1.2%
-1.2%
3 Month
-9.6%
-9.6%
6 Month
-0.1%
-0.1%
1 Year
+1831.1%
+1831.1%
More News
Read More
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?
↗
May 18, 2026
Via
The Motley Fool
Topics
ETFs
Regulatory Compliance
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing
↗
May 18, 2026
Via
The Motley Fool
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish
↗
May 18, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares
↗
May 17, 2026
Via
The Motley Fool
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares
↗
May 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million
↗
May 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
↗
May 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Abivax Announces Results of its May 11, 2026 Annual General Meeting
May 11, 2026
From
Abivax
Via
GlobeNewswire
Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares
May 05, 2026
From
Abivax
Via
GlobeNewswire
Abivax to Present Data on Obefazimod at Digestive Disease Week®
April 22, 2026
From
Abivax
Via
GlobeNewswire
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
April 20, 2026
From
Abivax
Via
GlobeNewswire
This Beaten-Down Drug Stock Is Down Over 10% -- Is It Finally a Buy?
↗
April 07, 2026
Via
The Motley Fool
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
April 01, 2026
From
Abivax
Via
GlobeNewswire
2 Healthcare Stocks That Could Soar Over the Next 5 Years
↗
March 26, 2026
Via
The Motley Fool
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
March 23, 2026
From
Abivax
Via
GlobeNewswire
Goldman Sachs Bullish Forecast: 15% Increase in 2026 U.S. M&A Activity
March 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
2 Healthcare Stocks to Buy Before They Get Bought Out
↗
March 20, 2026
Via
The Motley Fool
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally
↗
March 16, 2026
Via
The Motley Fool
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally
↗
March 16, 2026
Via
The Motley Fool
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know?
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Frequently Asked Questions
Is Abivax SA - American Depositary Shares publicly traded?
Yes, Abivax SA - American Depositary Shares is publicly traded.
What exchange does Abivax SA - American Depositary Shares trade on?
Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Abivax SA - American Depositary Shares?
The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market
What is the current price of Abivax SA - American Depositary Shares?
The current price of Abivax SA - American Depositary Shares is 113.55
When was Abivax SA - American Depositary Shares last traded?
The last trade of Abivax SA - American Depositary Shares was at 05/18/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.